Fierce Pharma September 7, 2023
By Nick Paul Taylor

PhRMA has rounded up its attack ad team once again for another broadside against pharmacy benefit managers, zeroing in this time on the potential for insurers to profit from where prescriptions get filled.

In recent years, the Big Pharma trade group has responded to criticisms of drug prices by running a string of ads about the effect of PBMs. PhRMA created the blueprint for the attack ads with the spots it ran in 2019 and 2021, and it returned for another round earlier this year in the wake of Congress’ vote to pass contentious drug pricing legislation.

The latest TV spot has the same structure as the two previous ads. In the new spot, titled “Middlemen Are...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Congress / White House, Govt Agencies, Pharma, Pharma / Biotech, Regulations
CVS, Walgreens & Walmart's healthcare strategy faces headwinds: 10 notes from 2024
FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions
The CMS NHE 2023 Report: An Incomplete Picture at a Pivotal Time
Mark Cuban's 2025 plans
Pharma At A Crossroads: Navigating Cost Pressures And Regulatory Shifts In 2025

Share This Article